With the development of advanced large-scale accelerator facilities, considerable quantities of activated material are now being produced. From both a scientific and a technological viewpoint, many of these nuclides are of great interest for future research, and in fact cannot be obtained through other means. The Paul Scherrer Institute—operating one of the most powerful proton accelerators in Europe—is able to provide considerable amounts of several exotic long-lived radionuclides. The present report is focused on the separation and application of radionuclides with a special interest on nuclear astrophysics topics.
No takes yet. Share an insight, caveat, or question.
Schumann et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: